Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (328)

« Back to Publications

Automated virtual reality therapy to treat needle fears (trypanophobia) in adolescents in England: a proof-of-concept cohort study and a Phase II randomised controlled trial

Freeman D. et al, (2026), Eclinicalmedicine, 97

Molnupiravir Treatment for COVID-19 in People at Higher Risk in the Community: Outcomes from the PANORAMIC Randomised Controlled Trial at Three and Six Months

Harris V. et al, (2026)

Economic Evaluation of Oral Nirmatrelvir-Ritonavir for COVID-19 in Higher Risk Outpatients

Png ME. et al, (2026), JAMA Network Open, 9

Nirmatrelvir–ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022–23: virological and immunological results of an open-label randomised trial (PANORAMIC)

Lowe DM. et al, (2026), Lancet Microbe, 7

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients

Butler CC. et al, (2026), New England Journal of Medicine, 394, 1583 - 1594

Optimising the monitoring and management of raised blood pressure including proteinuria testing during pregnancy: the BUMP research programme including 2 RCTs

Mcmanus RJ. et al, (2026), Programme Grants for Applied Research, 14, 1 - 30

Optimising Prescription of Treatment In older patients with Mild hypertension at Increased risk of Serious adverse Events (OPTIMISE2): protocol for a primary care based, open-label, randomised controlled non-inferiority trial

Carr M. et al, (2026), Trials, 27

Penicillin allergy assessment pathway to improve antibiotic use: the ALABAMA intervention development, RCT, process and cost-effectiveness evaluation

Sandoe JAT. et al, (2026), Programme Grants for Applied Research, 14

Testing a New Diabetes Adaptive Weight management Network (NewDAWN): A protocol for a randomised controlled trial

Guess N. et al, (2025), Contemporary Clinical Trials, 157

Real-world waitlist randomised controlled trial of gameChange VR to treat severe agoraphobic avoidance in patients with psychosis: A study protocol

Freeman D. et al, (2025), BMJ Open, 15

Ivermectin and COVID-19

Butler CC. et al, (2025), Journal of Infection, 91

Removal notice to “Ivermectin and COVID-19” Journal of Infection 91 (2025) 106530 (Journal of Infection (2025) 91(2), (S0163445325001240), (10.1016/j.jinf.2025.106530))

Butler CC. et al, (2025), Journal of Infection, 91

The PRINCIPLE randomised controlled open label platform trial of hydroxychloroquine for treating COVID19 in community based patients at high risk

Hobbs FDR. et al, (2025), Scientific Reports, 15

Penicillin allergy assessment pathway versus usual clinical care for primary care patients with a penicillin allergy record in the UK (ALABAMA): an open-label, multicentre, randomised controlled trial

Sandoe JAT. et al, (2025), The Lancet Primary Care, 1, 100006 - 100006

A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration

Nguyen BT. et al, (2025), Journal of Infectious Diseases, 231, e1080 - e1090

Load More

1
2
3
4
5
6
7
...
»